首页> 外文会议>Nanotechnology 2009 : Technical proceedings >Preliminary studies of new photosensitizer for photodynamic treatment of melanoma based on nanostructural forms of Bacteriochlorin p N-alkoxycycloimide alkoxyoxyme methyl ester
【24h】

Preliminary studies of new photosensitizer for photodynamic treatment of melanoma based on nanostructural forms of Bacteriochlorin p N-alkoxycycloimide alkoxyoxyme methyl ester

机译:基于细菌氯霉素p N-烷氧基环酰亚胺烷氧基氧基甲基酯的纳米结构形式的新型光敏剂对黑素瘤的光动力治疗的初步研究

获取原文
获取原文并翻译 | 示例

摘要

Method of photodynamic therapy (PDT) of malignancies is actively used in experimental and clinical oncology. This work is devoted to investigation of Bacteriochlorin p N-alkoxycycloimide alkoxyoxyme methyl ester which possesses its absorption band at 795-800 nm. We have estimated the applicability of PDT with this photosensitizer to treat melanoma.rnWe have developed nanostructural forms of the substance - micellar dispersions on a base of 4% aqueous solution of Cremophor EL and Emuxol-268 and PEG-liposomal dispersion.rnIn all forms photosensitizer was selectively accumulated in tumor in comparison to normal tissue. PDT on BDF, mice bearing B16 melanoma have shown high therapeutic efficiency with inhibition of tumor growth up to 91%, increase of animal lifespan exceeded 60%. Complete recovery was achieved for 35% of animals.
机译:恶性肿瘤的光动力疗法(PDT)方法在实验和临床肿瘤学中得到积极应用。这项工作致力于研究在795-800 nm处具有吸收带的细菌绿霉素p N-烷氧基环酰亚胺烷氧基氧基甲基酯。我们已经估计了该光敏剂在PDT中的适用性,以治疗黑色素瘤.rn我们已经开发了该物质的纳米结构形式-在4%的Cremophor EL和Emuxol-268水溶液以及PEG-脂质体分散体的基础上的胶束分散体。与正常组织相比,它选择性地聚集在肿瘤中。在BDF上的PDT,带有B16黑色素瘤的小鼠显示出高治疗效率,对肿瘤生长的抑制高达91%,动物寿命延长超过60%。 35%的动物完全康复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号